{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:10Z","timestamp":1787019910622,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T00:00:00Z","timestamp":1192665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T00:00:00Z","timestamp":1192665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To gain insight into factors that might affect results of future case-control studies, we performed an analysis of children with sepsis and purpura admitted to the paediatric intensive care unit (PICU) of Erasmus MC-Sophia Children's Hospital (Rotterdam, The Netherlands).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Between 1988 and 2006, all 287 children consecutively admitted with sepsis and purpura were included in various sepsis studies. Data regarding age, gender, ethnicity, serogroup of\n                      <jats:italic>Neisseria meningitidis<\/jats:italic>\n                      , severity, therapy, and survival were collected prospectively. These data were pooled into one database and analyzed retrospectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The case fatality rate (CFR) from sepsis and purpura was 15.7%. During the study period, survival improved significantly. Younger age was significantly associated with more severe disease and a higher CFR. Children under the median age of 3.0 years had an increased risk of case fatality (odds ratio 4.3, 95% confidence interval 2.1 to 9.2;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Gender was not associated with CFR. However, males did have higher Paediatric Risk of Mortality scores, fewer PICU-free days, and more presence of shock. The course of sepsis and purpura was not related to ethnic origin. A causative organism was isolated in 84.3% of cases.\n                      <jats:italic>N. meningitidis<\/jats:italic>\n                      was the major organism (97.5%). Although\n                      <jats:italic>N. meningitidis<\/jats:italic>\n                      serogroup B was observed more often in younger children, serogroups were not associated with severity or survival. During the study period, the use of inotropic agents and corticosteroids changed substantially (less dopamine and more dobutamine, norepinephrine, and corticosteroids).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Age and gender are determinants of severity of paediatric sepsis and purpura. Survival rates have improved during the last two decades.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/cc6161","type":"journal-article","created":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T14:13:49Z","timestamp":1192716829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Improved survival of children with sepsis and purpura: effects of age, gender, and era"],"prefix":"10.1186","volume":"11","author":[{"given":"Martine","family":"Maat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne MP","family":"Buysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Emonts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk","family":"Spanjaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen FM","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A","family":"Hazelzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,18]]},"reference":[{"key":"5587_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM: Meningococcal disease.\n                           N Engl J Med 2001, 344: 1378-1388. 10.1056\/NEJM200105033441807","journal-title":"N Engl J Med"},{"key":"5587_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","volume":"420","author":"J Cohen","year":"2002","unstructured":"Cohen J: The immunopathogenesis of sepsis.\n                           Nature 2002, 420: 885-891. 10.1038\/nature01326","journal-title":"Nature"},{"issue":"3 Suppl","key":"5587_CR3","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/01.PCC.0000161947.57506.D6","volume":"6","author":"JA Hazelzet","year":"2005","unstructured":"Hazelzet JA: Diagnosing meningococcemia as a cause of sepsis.\n                           Pediatr Crit Care Med 2005,6(3 Suppl):S50-54. 10.1097\/01.PCC.0000161947.57506.D6","journal-title":"Pediatr Crit Care Med"},{"key":"5587_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/cc1454","volume":"6","author":"CL Vermont","year":"2002","unstructured":"Vermont CL, de Groot R, Hazelzet JA: Bench-to-bedside review: genetic influences on meningococcal disease.\n                           Crit Care 2002, 6: 60-65. 10.1186\/cc1454","journal-title":"Crit Care"},{"key":"5587_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1309\/3489075U03LMK9AE","volume":"122","author":"J Guarner","year":"2004","unstructured":"Guarner J, Greer PW, Whitney A, Shieh WJ, Fischer M, White EH, Carlone GM, Stephens DS, Popovic T, Zaki SR: Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays.\n                           Am J Clin Pathol 2004, 122: 754-764. 10.1309\/3489-075U-03LM-K9AE","journal-title":"Am J Clin Pathol"},{"key":"5587_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(03)00740-0","volume":"3","author":"M Emonts","year":"2003","unstructured":"Emonts M, Hazelzet JA, de Groot R, Hermans PW: Host genetic determinants of\n                           Neisseria meningitidis\n                           infections.\n                           Lancet Infect Dis 2003, 3: 565-577. 10.1016\/S1473-3099(03)00740-0","journal-title":"Lancet Infect Dis"},{"issue":"Pt 2","key":"5587_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1099\/jmm.0.04817-0","volume":"52","author":"ES Jensen","year":"2003","unstructured":"Jensen ES, Schonheyder HC, Lind I, Berthelsen L, Norgard B, Sorensen HT: Neisseria meningitidis\n                           phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county.\n                           J Med Microbiol 2003,52(Pt 2):173-179. 10.1099\/jmm.0.04817-0","journal-title":"J Med Microbiol"},{"key":"5587_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/adc.85.5.386","volume":"85","author":"R Booy","year":"2001","unstructured":"Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, Levin M, Meningococcal Research Group: Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.\n                           Arch Dis Child 2001, 85: 386-390. 10.1136\/adc.85.5.386","journal-title":"Arch Dis Child"},{"key":"5587_CR9","unstructured":"Netherlands Reference Lab for Bacterial Meningitis. Bacterial Meningitis in The Netherlands 2001 Amsterdam, The Netherlands: University of Amsterdam; 2002."},{"key":"5587_CR10","unstructured":"Netherlands Reference Lab for Bacterial Meningitis. Bacterial Meningitis in The Netherlands 2002 Amsterdam, The Netherlands: University of Amsterdam; 2003:11."},{"key":"5587_CR11","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1097\/01.CCM.0000171272.50888.AD","volume":"33","author":"CL Vermont","year":"2005","unstructured":"Vermont CL, den Brinker M, K\u00e2keci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA: Serum lipids and disease severity in children with severe meningococcal sepsis.\n                           Crit Care Med 2005, 33: 1610-1615. 10.1097\/01.CCM.0000171272.50888.AD","journal-title":"Crit Care Med"},{"key":"5587_CR12","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2005-1107","volume":"90","author":"M den Brinker","year":"2005","unstructured":"den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC: Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality.\n                           J Clin Endocrinol Metab 2005, 90: 5110-5117. 10.1210\/jc.2005-1107","journal-title":"J Clin Endocrinol Metab"},{"key":"5587_CR13","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1210\/jcem.87.7.8605","volume":"87","author":"F de Groof","year":"2002","unstructured":"de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC: Acute stress response in children with meningococcal sepsis: important differences in the growth hormone\/insulin-like growth factor I axis between nonsurvivors and survivors.\n                           J Clin Endocrinol Metab 2002, 87: 3118-3124. 10.1210\/jc.87.7.3118","journal-title":"J Clin Endocrinol Metab"},{"key":"5587_CR14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","volume":"31","author":"ED de Kleijn","year":"2003","unstructured":"de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.\n                           Crit Care Med 2003, 31: 1839-1847. 10.1097\/01.CCM.0000072121.61120.D8","journal-title":"Crit Care Med"},{"key":"5587_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/515184","volume":"28","author":"B Derkx","year":"1999","unstructured":"Derkx B, Wittes J, McCloskey R: Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.\n                           Clin Infect Dis 1999, 28: 770-777. 10.1086\/515184","journal-title":"Clin Infect Dis"},{"key":"5587_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s00134-002-1505-1","volume":"28","author":"DC Van der Kaay","year":"2002","unstructured":"Van der Kaay DC, De Kleijn ED, De Rijke YB, Hop WC, De Groot R, Hazelzet JA: Procalcitonin as a prognostic marker in meningococcal disease.\n                           Intensive Care Med 2002, 28: 1606-1612. 10.1007\/s00134-002-1505-1","journal-title":"Intensive Care Med"},{"key":"5587_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.\n                           Pediatr Crit Care Med 2005, 6: 2-8. 10.1097\/01.PCC.0000149131.72248.E6","journal-title":"Pediatr Crit Care Med"},{"key":"5587_CR18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/01.CCM.0000146133.52982.17","volume":"32","author":"AF Zuppa","year":"2004","unstructured":"Zuppa AF, Nadkarni V, Davis L, Adamson PC, Helfaer MA, Elliott MR, Abrams J, Durbin D: The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.\n                           Crit Care Med 2004, 32: 2318-2322.","journal-title":"Crit Care Med"},{"key":"5587_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/513759","volume":"25","author":"RF Kornelisse","year":"1997","unstructured":"Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R: Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score.\n                           Clin Infect Dis 1997, 25: 640-646. 10.1086\/513759","journal-title":"Clin Infect Dis"},{"key":"5587_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/00003246-198811000-00006","volume":"16","author":"MM Pollack","year":"1988","unstructured":"Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score.\n                           Crit Care Med 1988, 16: 1110-1116.","journal-title":"Crit Care Med"},{"key":"5587_CR21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.\n                           Thromb Haemost 2001, 86: 1327-1330.","journal-title":"Thromb Haemost"},{"key":"5587_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1024205226239","volume":"18","author":"CB Bouwhuis","year":"2003","unstructured":"Bouwhuis CB, Moll HA: Determination of ethnicity in children in The Netherlands: two methods compared.\n                           Eur J Epidemiol 2003, 18: 385-388. 10.1023\/A:1024205226239","journal-title":"Eur J Epidemiol"},{"key":"5587_CR23","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/jcm.33.12.3326-3327.1995","volume":"33","author":"A van der Ende","year":"1995","unstructured":"van der Ende A, Schuurman IG, Hopman CT, Fijen CA, Dankert J: Comparison of commercial diagnostic tests for identification of serogroup antigens of\n                           Neisseria meningitidis\n                           .\n                           J Clin Microbiol 1995, 33: 3326-3327.","journal-title":"J Clin Microbiol"},{"key":"5587_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.inf.0000202065.03366.0c","volume":"25","author":"A Sharip","year":"2006","unstructured":"Sharip A, Sorvillo F, Redelings MD, Mascola L, Wise M, Nguyen DM: Population-based analysis of meningococcal disease mortality in the United States: 1990\u20132002.\n                           Pediatr Infect Dis J 2006, 25: 191-194. 10.1097\/01.inf.0000202065.03366.0c","journal-title":"Pediatr Infect Dis J"},{"key":"5587_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","volume":"13","author":"M van Deuren","year":"2000","unstructured":"van Deuren M, Brandtzaeg P, van der Meer JW: Update on meningococcal disease with emphasis on pathogenesis and clinical management.\n                           Clin Microbiol Rev 2000, 13: 144-166.","journal-title":"Clin Microbiol Rev"},{"key":"5587_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1164\/rccm.200207-682OC","volume":"167","author":"RS Watson","year":"2003","unstructured":"Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC: The epidemiology of severe sepsis in children in the United States.\n                           Am J Respir Crit Care Med 2003, 167: 695-701. 10.1164\/rccm.200207-682OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5587_CR27","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000.\n                           N Engl J Med 2003, 348: 1546-1554. 10.1056\/NEJMoa022139","journal-title":"N Engl J Med"},{"key":"5587_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/520303","volume":"26","author":"L Erickson","year":"1998","unstructured":"Erickson L, De Wals P: Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994.\n                           Clin Infect Dis 1998, 26: 1159-1164. 10.1086\/520303","journal-title":"Clin Infect Dis"},{"key":"5587_CR29","first-page":"861","volume":"65","author":"L Spanjaard","year":"1987","unstructured":"Spanjaard L, Bol P, de Marie S, Zanen HC: Association of meningococcal serogroups with the course of disease in the Netherlands, 1959\u201383.\n                           Bull World Health Organ 1987, 65: 861-868.","journal-title":"Bull World Health Organ"},{"key":"5587_CR30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1007\/s00134-003-1948-z","volume":"29","author":"L Bindl","year":"2003","unstructured":"Bindl L, Buderus S, Dahlem P, Demirakca S, Goldner M, Huth R, Kohl M, Krause M, K\u00fchl P, Lasch P, ESPNIC ARDS Database Group, et al.: Gender-based differences in children with sepsis and ARDS: the ESPNIC ARDS Database Group.\n                           Intensive Care Med 2003, 29: 1770-1773. 10.1007\/s00134-003-1948-z","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc6161\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:30:19Z","timestamp":1728289819000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc6161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,18]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,10]]}},"alternative-id":["5587"],"URL":"https:\/\/doi.org\/10.1186\/cc6161","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,18]]},"assertion":[{"value":"18 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2007","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R112"}}